| Crystal structure of the β2 adrenergic receptor–Gs protein complex SGF Rasmussen, BT DeVree, Y Zou, AC Kruse, KY Chung, TS Kobilka, ... Nature 477 (7366), 549-555, 2011 | 3213 | 2011 |
| Conformational changes in the G protein Gs induced by the β2 adrenergic receptor KY Chung, SGF Rasmussen, T Liu, S Li, BT DeVree, PS Chae, D Calinski, ... Nature 477 (7366), 611-615, 2011 | 412 | 2011 |
| Structural flexibility of the Gαs α-helical domain in the β2-adrenoceptor Gs complex GH Westfield, SGF Rasmussen, M Su, S Dutta, BT DeVree, KY Chung, ... Proceedings of the National Academy of Sciences 108 (38), 16086-16091, 2011 | 267 | 2011 |
| Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types X Ling, D Calinski, AA Chanan-Khan, M Zhou, F Li Journal of Experimental & Clinical Cancer Research 29 (1), 1-10, 2010 | 71 | 2010 |
| Food restriction alters N′-propyl-4, 5, 6, 7-tetrahydrobenzothiazole-2, 6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats … GT Collins, DM Calinski, AH Newman, P Grundt, JH Woods Journal of Pharmacology and Experimental Therapeutics 325 (2), 691-697, 2008 | 55 | 2008 |
| A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics DM Calinski, DF Kisor, JE Sprague Psychopharmacology 236, 881-890, 2019 | 37 | 2019 |
| The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir H Lin, J D’Agostino, C Kenaan, D Calinski, PF Hollenberg Drug Metabolism and Disposition 41 (10), 1813-1824, 2013 | 27 | 2013 |
| Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms DM Calinski, H Zhang, S Ludeman, ME Dolan, PF Hollenberg Drug Metabolism and Disposition 43 (7), 1084-1090, 2015 | 20 | 2015 |
| An Interdisciplinary Experience focused on Pharmacogenetics: Engaging pharmacy and physician assistant students in conversations about antiplatelet therapy with respect to … DM Calinski, DF Kisor INNOVATIONS in pharmacy 7 (1), 2016 | 9 | 2016 |
| Beyond the didactic lecture: pharmacogenomics in pharmacy education DF Kisor, DM Calinski, CL Farrell Personalized Medicine 15 (1), 9-12, 2018 | 8 | 2018 |
| An interprofessional education experience to promote the role of the pharmacist in precision medicine DM Calinski, C Hoefer, D Kisor Currents in Pharmacy Teaching and Learning 13 (10), 1370-1375, 2021 | 3 | 2021 |
| Pharmacogenetic considerations in the elderly patient DR Bright, DM Calinski, DF Kisor The Consultant PharmacistŪ 30 (4), 228-239, 2015 | 3 | 2015 |
| Metabolism of cyclophosphamide by CYP 2B6 and associated polymorphisms JM Abbott, D Calinski, P Hollenberg The FASEB Journal 27, 1007.7-1007.7, 2013 | 2 | 2013 |
| Complex patient cases solved by near-peer integrated teams provides leadership, professionalism, and peer-teaching opportunities B Henriksen, D Calinski, J Henriksen, N Gregory Currents in Pharmacy Teaching and Learning 12 (12), 1477-1483, 2020 | 1 | 2020 |
| Use of Model Membranes to Study GPCR Signalling Units: Insights into Monomers and Oligomers DM Calinski, E Edwald, RK Sunahara G Protein-Coupled Receptors, 179-196, 2011 | 1 | 2011 |
| Linking Pharmacology to Clinical Therapeutics: An Interdisciplinary Laboratory Experience in Optimizing Antiplatelet Therapy using Pharmacogenetic Data D Calinski, D Kisor The FASEB Journal 29, 928.6, 2015 | | 2015 |
| Oxazaphosphorine metabolism by the human cytochrome P450s and some commonly expressed P450 polymorphic variants DM Calinski University of Michigan, 2013 | | 2013 |
| Abstract# 417: Survivin expression and sensitivity of cancer cells to treatment with bortezomib X Ling, D Calinski, A Chanan-Khan, F Li Cancer Research 69 (9_Supplement), 417-417, 2009 | | 2009 |
| Characterization of the expression, subcellular localization and function of survivin-3B, a survivin splice variant, using a newly generated survivin-3B-specific antibody and … X Ling, D Calinski, F Li Cancer Research 68 (9_Supplement), 4140-4140, 2008 | | 2008 |
| Food restriction alters pramipexole‐induced yawning, hypothermia, and locomotor activity in rats: Evidence for sensitization of D2, but not D3 receptor‐mediated effects GT Collins, DM Calinski, JH Woods The FASEB Journal 22, 904.5-904.5, 2008 | | 2008 |
Gregory T CollinsAssociate Professor; Dept of Pharmacology; UT Health San AntonioVerified email at uthscsa.edu
